Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2022-05-02 Sale |
2022-05-03 7:03 pm |
Nurix Therapeutics Inc. | NRIX | Ring Christine General Counsel |
660 | $11.75 | $7,755 | 32,264 (Direct) |
View |
| 2022-01-10 Sale |
2022-01-11 4:10 pm |
Nurix Therapeutics Inc. | NRIX | Ring Christine General Counsel |
1,200 | $27.14 | $32,568 | 101,352 (Direct) |
View |
| 2022-01-03 Sale |
2022-01-04 4:19 pm |
Nurix Therapeutics Inc. | NRIX | Hansen Gwenn Chief Scientific Officer |
1,828 | $28.96 | $52,939 | 163,568 (Direct) |
View |
| 2021-12-10 Sale |
2021-12-13 4:47 pm |
Nurix Therapeutics Inc. | NRIX | Ring Christine General Counsel |
1,200 | $29.04 | $34,848 | 102,552 (Direct) |
View |
| 2021-12-01 Sale |
2021-12-02 5:43 pm |
Nurix Therapeutics Inc. | NRIX | Hansen Gwenn Chief Scientific Officer |
400 | $29.13 | $11,652 | 82,063 (Direct) |
View |
| 2021-11-10 Sale |
2021-11-12 5:15 pm |
Nurix Therapeutics Inc. | NRIX | Ring Christine General Counsel |
1,200 | $32.38 | $38,856 | 103,752 (Direct) |
View |
| 2021-11-01 Sale |
2021-11-02 5:28 pm |
Nurix Therapeutics Inc. | NRIX | Hansen Gwenn Chief Scientific Officer |
400 | $33.24 | $13,296 | 82,463 (Direct) |
View |
| 2021-10-27 Sale |
2021-10-28 7:25 pm |
Nurix Therapeutics Inc. | NRIX | Ring Christine General Counsel |
800 | $35.25 | $28,200 | 104,952 (Direct) |
View |
| 2021-10-27 Sale |
2021-10-28 7:23 pm |
Nurix Therapeutics Inc. | NRIX | Hansen Gwenn Chief Scientific Officer |
400 | $35 | $14,000 | 82,863 (Direct) |
View |
| 2021-10-11 Sale |
2021-10-12 6:43 pm |
Nurix Therapeutics Inc. | NRIX | Ring Christine General Counsel |
1,200 | $27.36 | $32,832 | 105,752 (Direct) |
View |
| 2021-10-01 Sale |
2021-10-04 5:16 pm |
Nurix Therapeutics Inc. | NRIX | Hansen Gwenn Chief Scientific Officer |
400 | $29.92 | $11,968 | 83,263 (Direct) |
View |
| 2021-09-10 Sale |
2021-09-13 4:07 pm |
Nurix Therapeutics Inc. | NRIX | Ring Christine General Counsel |
2,000 | $35.93 | $71,860 | 106,952 (Direct) |
View |
| 2021-09-07 Sale |
2021-09-08 5:08 pm |
Nurix Therapeutics Inc. | NRIX | Ring Christine General Counsel |
3,200 | $35.25 | $112,800 | 108,952 (Direct) |
View |
| 2021-09-07 Sale |
2021-09-08 5:08 pm |
Nurix Therapeutics Inc. | NRIX | Hansen Gwenn Chief Scientific Officer |
1,600 | $35 | $56,000 | 83,663 (Direct) |
View |
| 2021-09-01 Sale |
2021-09-02 4:22 pm |
Nurix Therapeutics Inc. | NRIX | Hansen Gwenn Chief Scientific Officer |
400 | $32.34 | $12,936 | 85,263 (Direct) |
View |
| 2021-08-10 Sale |
2021-08-11 6:21 pm |
Nurix Therapeutics Inc. | NRIX | Ring Christine General Counsel |
1,200 | $29.87 | $35,845 | 111,671 (Direct) |
View |
| 2021-08-10 Sale |
2021-08-11 6:20 pm |
Nurix Therapeutics Inc. | NRIX | Beaurang Pierre Chief Business Officer |
7,500 | $29.86 | $223,926 | 127,558 (Indirect Direct) |
View |
| 2021-08-02 Sale |
2021-08-03 5:39 pm |
Nurix Therapeutics Inc. | NRIX | Hansen Gwenn Chief Scientific Officer |
400 | $31.21 | $12,484 | 85,270 (Direct) |
View |
| 2021-07-20 Sale |
2021-07-21 5:34 pm |
Nurix Therapeutics Inc. | NRIX | Ring Christine General Counsel |
1,200 | $27 | $32,400 | 112,871 (Direct) |
View |
| 2021-07-12 Sale |
2021-07-12 7:36 pm |
Nurix Therapeutics Inc. | NRIX | Beaurang Pierre Chief Business Officer |
7,500 | $23.92 | $179,419 | 135,058 (Indirect Direct) |
View |
| 2021-07-01 Sale |
2021-07-02 4:03 pm |
Nurix Therapeutics Inc. | NRIX | Hansen Gwenn Chief Scientific Officer |
400 | $26.76 | $10,704 | 85,670 (Direct) |
View |
| 2021-06-10 Sale |
2021-06-11 4:11 pm |
Nurix Therapeutics Inc. | NRIX | Ring Christine General Counsel |
1,200 | $29.4 | $35,282 | 114,071 (Direct) |
View |
| 2021-06-10 Sale |
2021-06-11 4:10 pm |
Nurix Therapeutics Inc. | NRIX | Beaurang Pierre Chief Business Officer |
7,500 | $29.37 | $220,248 | 142,558 (Indirect Direct) |
View |
| 2021-06-01 Sale |
2021-06-02 4:49 pm |
Nurix Therapeutics Inc. | NRIX | Hansen Gwenn Chief Scientific Officer |
400 | $27.74 | $11,096 | 86,070 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2022-04-30 Exercise |
2022-05-03 7:03 pm |
N/A N/A |
Nurix Therapeutics Inc. | NRIX | Ring Christine General Counsel |
1,924 | $0 | 32,264 (Direct) |
View |
| 2022-01-20 Option Award |
2022-01-21 4:25 pm |
N/A 2032-01-19 |
Nurix Therapeutics Inc. | NRIX | SANDS ARTHUR T President, CEO |
300,000 | $0 | 300,000 (Direct) |
View |
| 2022-01-19 Option Award |
2022-01-21 4:17 pm |
N/A 2032-01-18 |
Nurix Therapeutics Inc. | NRIX | Wolff Stefani EVP and COO |
50,023 | $0 | 50,023 (Direct) |
View |
| 2022-01-19 Option Award |
2022-01-21 4:16 pm |
N/A 2032-01-18 |
Nurix Therapeutics Inc. | NRIX | van Houte Hans Chief Financial Officer |
150,071 | $0 | 150,071 (Direct) |
View |
| 2022-01-19 Option Award |
2022-01-21 4:15 pm |
N/A 2032-01-18 |
Nurix Therapeutics Inc. | NRIX | Ring Christine General Counsel |
100,047 | $0 | 100,047 (Direct) |
View |
| 2022-01-19 Option Award |
2022-01-21 4:14 pm |
N/A 2032-01-18 |
Nurix Therapeutics Inc. | NRIX | Hansen Gwenn Chief Scientific Officer |
166,746 | $0 | 166,746 (Direct) |
View |
| 2022-01-10 Exercise |
2022-01-11 4:10 pm |
N/A N/A |
Nurix Therapeutics Inc. | NRIX | Ring Christine General Counsel |
1,200 | $1.86 | 101,352 (Direct) |
View |
| 2022-01-10 Exercise |
2022-01-11 4:10 pm |
N/A 2029-09-30 |
Nurix Therapeutics Inc. | NRIX | Ring Christine General Counsel |
1,200 | $0 | 101,352 (Direct) |
View |
| 2022-01-03 Exercise |
2022-01-04 4:19 pm |
N/A N/A |
Nurix Therapeutics Inc. | NRIX | Hansen Gwenn Chief Scientific Officer |
400 | $7.26 | 163,568 (Direct) |
View |
| 2022-01-03 Exercise |
2022-01-04 4:19 pm |
N/A N/A |
Nurix Therapeutics Inc. | NRIX | Hansen Gwenn Chief Scientific Officer |
1,428 | $9.57 | 163,568 (Direct) |
View |
| 2022-01-03 Exercise |
2022-01-04 4:19 pm |
N/A 2030-02-26 |
Nurix Therapeutics Inc. | NRIX | Hansen Gwenn Chief Scientific Officer |
1,828 | $0 | 163,568 (Direct) |
View |
| 2021-12-10 Exercise |
2021-12-13 4:47 pm |
N/A N/A |
Nurix Therapeutics Inc. | NRIX | Ring Christine General Counsel |
1,200 | $1.86 | 102,552 (Direct) |
View |
| 2021-12-10 Exercise |
2021-12-13 4:47 pm |
N/A 2029-09-30 |
Nurix Therapeutics Inc. | NRIX | Ring Christine General Counsel |
1,200 | $0 | 102,552 (Direct) |
View |
| 2021-12-01 Exercise |
2021-12-02 5:43 pm |
N/A N/A |
Nurix Therapeutics Inc. | NRIX | Hansen Gwenn Chief Scientific Officer |
400 | $7.26 | 82,063 (Direct) |
View |
| 2021-12-01 Exercise |
2021-12-02 5:43 pm |
N/A 2030-02-26 |
Nurix Therapeutics Inc. | NRIX | Hansen Gwenn Chief Scientific Officer |
400 | $0 | 82,063 (Direct) |
View |
| 2021-11-10 Exercise |
2021-11-12 5:15 pm |
N/A N/A |
Nurix Therapeutics Inc. | NRIX | Ring Christine General Counsel |
1,200 | $1.86 | 103,752 (Direct) |
View |
| 2021-11-10 Exercise |
2021-11-12 5:15 pm |
N/A 2029-09-30 |
Nurix Therapeutics Inc. | NRIX | Ring Christine General Counsel |
1,200 | $0 | 103,752 (Direct) |
View |
| 2021-11-01 Exercise |
2021-11-02 5:28 pm |
N/A N/A |
Nurix Therapeutics Inc. | NRIX | Hansen Gwenn Chief Scientific Officer |
400 | $7.26 | 82,463 (Direct) |
View |
| 2021-11-01 Exercise |
2021-11-02 5:28 pm |
N/A 2030-02-26 |
Nurix Therapeutics Inc. | NRIX | Hansen Gwenn Chief Scientific Officer |
400 | $0 | 82,463 (Direct) |
View |
| 2021-10-27 Exercise |
2021-10-28 7:25 pm |
N/A N/A |
Nurix Therapeutics Inc. | NRIX | Ring Christine General Counsel |
800 | $1.86 | 104,952 (Direct) |
View |
| 2021-10-27 Exercise |
2021-10-28 7:25 pm |
N/A 2029-09-30 |
Nurix Therapeutics Inc. | NRIX | Ring Christine General Counsel |
800 | $0 | 104,952 (Direct) |
View |
| 2021-10-27 Exercise |
2021-10-28 7:23 pm |
N/A N/A |
Nurix Therapeutics Inc. | NRIX | Hansen Gwenn Chief Scientific Officer |
400 | $7.26 | 82,863 (Direct) |
View |
| 2021-10-27 Exercise |
2021-10-28 7:23 pm |
N/A 2030-02-26 |
Nurix Therapeutics Inc. | NRIX | Hansen Gwenn Chief Scientific Officer |
400 | $0 | 82,863 (Direct) |
View |
| 2021-10-11 Exercise |
2021-10-12 6:43 pm |
N/A N/A |
Nurix Therapeutics Inc. | NRIX | Ring Christine General Counsel |
1,200 | $1.86 | 105,752 (Direct) |
View |
| 2021-10-11 Exercise |
2021-10-12 6:43 pm |
N/A 2029-09-30 |
Nurix Therapeutics Inc. | NRIX | Ring Christine General Counsel |
1,200 | $0 | 105,752 (Direct) |
View |
| 2021-10-01 Exercise |
2021-10-04 5:16 pm |
N/A N/A |
Nurix Therapeutics Inc. | NRIX | Hansen Gwenn Chief Scientific Officer |
400 | $7.26 | 83,263 (Direct) |
View |
| 2021-10-01 Exercise |
2021-10-04 5:16 pm |
N/A 2030-02-26 |
Nurix Therapeutics Inc. | NRIX | Hansen Gwenn Chief Scientific Officer |
400 | $0 | 83,263 (Direct) |
View |
| 2021-10-01 Option Award |
2021-10-04 5:16 pm |
N/A 2031-09-30 |
Nurix Therapeutics Inc. | NRIX | Reinsdorf Judith A Director |
35,000 | $0 | 35,000 (Direct) |
View |
| 2021-10-01 Option Award |
2021-10-04 5:15 pm |
N/A 2031-09-30 |
Nurix Therapeutics Inc. | NRIX | Silva Paul M Director |
35,000 | $0 | 35,000 (Direct) |
View |
| 2021-09-10 Exercise |
2021-09-13 4:07 pm |
N/A N/A |
Nurix Therapeutics Inc. | NRIX | Ring Christine General Counsel |
2,000 | $1.86 | 106,952 (Direct) |
View |
| 2021-09-10 Exercise |
2021-09-13 4:07 pm |
N/A 2029-09-30 |
Nurix Therapeutics Inc. | NRIX | Ring Christine General Counsel |
2,000 | $0 | 106,952 (Direct) |
View |
| 2021-09-07 Exercise |
2021-09-08 5:08 pm |
N/A N/A |
Nurix Therapeutics Inc. | NRIX | Ring Christine General Counsel |
3,200 | $1.86 | 108,952 (Direct) |
View |
| 2021-09-07 Exercise |
2021-09-08 5:08 pm |
N/A 2029-09-30 |
Nurix Therapeutics Inc. | NRIX | Ring Christine General Counsel |
3,200 | $0 | 108,952 (Direct) |
View |
| 2021-09-07 Exercise |
2021-09-08 5:08 pm |
N/A N/A |
Nurix Therapeutics Inc. | NRIX | Hansen Gwenn Chief Scientific Officer |
1,600 | $7.26 | 83,663 (Direct) |
View |
| 2021-09-07 Exercise |
2021-09-08 5:08 pm |
N/A 2030-02-26 |
Nurix Therapeutics Inc. | NRIX | Hansen Gwenn Chief Scientific Officer |
1,600 | $0 | 83,663 (Direct) |
View |
| 2021-09-01 Exercise |
2021-09-02 4:22 pm |
N/A N/A |
Nurix Therapeutics Inc. | NRIX | Hansen Gwenn Chief Scientific Officer |
400 | $7.26 | 85,263 (Direct) |
View |
| 2021-09-01 Exercise |
2021-09-02 4:22 pm |
N/A 2030-02-26 |
Nurix Therapeutics Inc. | NRIX | Hansen Gwenn Chief Scientific Officer |
400 | $0 | 85,263 (Direct) |
View |
Ownership |
2021-08-17 5:19 pm |
N/A 2031-07-12 |
Nurix Therapeutics Inc. | NRIX | Wolff Stefani EVP and COO |
0 | $0 | 443,865 (Direct) |
View |
| 2021-08-10 Exercise |
2021-08-11 6:21 pm |
N/A N/A |
Nurix Therapeutics Inc. | NRIX | Ring Christine General Counsel |
1,200 | $1.86 | 111,671 (Direct) |
View |
| 2021-08-10 Exercise |
2021-08-11 6:21 pm |
N/A 2029-09-30 |
Nurix Therapeutics Inc. | NRIX | Ring Christine General Counsel |
1,200 | $0 | 111,671 (Direct) |
View |
| 2021-08-10 Exercise |
2021-08-11 6:20 pm |
N/A N/A |
Nurix Therapeutics Inc. | NRIX | Beaurang Pierre Chief Business Officer |
7,500 | $1.11 | 127,558 (Direct) |
View |
| 2021-08-10 Exercise |
2021-08-11 6:20 pm |
N/A 2027-02-01 |
Nurix Therapeutics Inc. | NRIX | Beaurang Pierre Chief Business Officer |
7,500 | $0 | 127,558 (Direct) |
View |
| 2021-08-02 Exercise |
2021-08-03 5:39 pm |
N/A N/A |
Nurix Therapeutics Inc. | NRIX | Hansen Gwenn Chief Scientific Officer |
400 | $7.26 | 85,270 (Direct) |
View |
| 2021-08-02 Exercise |
2021-08-03 5:39 pm |
N/A 2030-02-26 |
Nurix Therapeutics Inc. | NRIX | Hansen Gwenn Chief Scientific Officer |
400 | $0 | 85,270 (Direct) |
View |
| 2021-07-20 Exercise |
2021-07-21 5:34 pm |
N/A N/A |
Nurix Therapeutics Inc. | NRIX | Ring Christine General Counsel |
1,200 | $1.86 | 112,871 (Direct) |
View |
| 2021-07-20 Exercise |
2021-07-21 5:34 pm |
N/A 2029-09-30 |
Nurix Therapeutics Inc. | NRIX | Ring Christine General Counsel |
1,200 | $0 | 112,871 (Direct) |
View |
| 2021-07-12 Exercise |
2021-07-12 7:36 pm |
N/A N/A |
Nurix Therapeutics Inc. | NRIX | Beaurang Pierre Chief Business Officer |
7,500 | $1.11 | 135,058 (Direct) |
View |
| 2021-07-12 Exercise |
2021-07-12 7:36 pm |
N/A 2027-02-01 |
Nurix Therapeutics Inc. | NRIX | Beaurang Pierre Chief Business Officer |
7,500 | $0 | 135,058 (Direct) |
View |
| 2021-07-01 Exercise |
2021-07-02 4:03 pm |
N/A N/A |
Nurix Therapeutics Inc. | NRIX | Hansen Gwenn Chief Scientific Officer |
400 | $7.26 | 85,670 (Direct) |
View |
| 2021-07-01 Exercise |
2021-07-02 4:03 pm |
N/A 2030-02-26 |
Nurix Therapeutics Inc. | NRIX | Hansen Gwenn Chief Scientific Officer |
400 | $0 | 85,670 (Direct) |
View |
| 2021-06-10 Exercise |
2021-06-11 4:11 pm |
N/A N/A |
Nurix Therapeutics Inc. | NRIX | Ring Christine General Counsel |
1,200 | $1.86 | 114,071 (Direct) |
View |
| 2021-06-10 Exercise |
2021-06-11 4:11 pm |
N/A 2029-09-30 |
Nurix Therapeutics Inc. | NRIX | Ring Christine General Counsel |
1,200 | $0 | 114,071 (Direct) |
View |
| 2021-06-10 Exercise |
2021-06-11 4:10 pm |
N/A N/A |
Nurix Therapeutics Inc. | NRIX | Beaurang Pierre Chief Business Officer |
7,500 | $1.11 | 142,558 (Direct) |
View |
| 2021-06-10 Exercise |
2021-06-11 4:10 pm |
N/A 2027-02-01 |
Nurix Therapeutics Inc. | NRIX | Beaurang Pierre Chief Business Officer |
7,500 | $0 | 142,558 (Direct) |
View |
| 2021-06-01 Exercise |
2021-06-02 4:49 pm |
N/A N/A |
Nurix Therapeutics Inc. | NRIX | Hansen Gwenn Chief Scientific Officer |
400 | $7.26 | 86,070 (Direct) |
View |
| 2021-06-01 Exercise |
2021-06-02 4:49 pm |
N/A 2030-02-26 |
Nurix Therapeutics Inc. | NRIX | Hansen Gwenn Chief Scientific Officer |
400 | $0 | 86,070 (Direct) |
View |
| 2021-05-28 Option Award |
2021-06-01 4:21 pm |
N/A 2031-05-27 |
Nurix Therapeutics Inc. | NRIX | SIEGALL CLAY B Director |
35,000 | $0 | 35,000 (Direct) |
View |
| 2021-05-06 Option Award |
2021-05-24 7:50 pm |
N/A 2031-05-05 |
Nurix Therapeutics Inc. | NRIX | Tong Jeffrey K Director 10% Owner |
17,500 | $0 | 17,500 (Direct) |
View |
| 2021-05-06 Option Award |
2021-05-24 7:49 pm |
N/A 2031-05-05 |
Nurix Therapeutics Inc. | NRIX | Lacey David L. Director |
17,500 | $0 | 17,500 (Direct) |
View |
| 2021-05-06 Option Award |
2021-05-24 7:49 pm |
N/A 2031-05-05 |
Nurix Therapeutics Inc. | NRIX | Kunkel Lori Anne Director |
17,500 | $0 | 17,500 (Direct) |
View |
| 2021-05-06 Option Award |
2021-05-24 7:48 pm |
N/A 2031-05-05 |
Nurix Therapeutics Inc. | NRIX | GREGORY JULIA P Director |
17,500 | $0 | 17,500 (Direct) |
View |